Emerging Radionuclides in RLT: What Developers Need to Know
Introduction Radioligand therapy (RLT) is an advanced oncological treatment which couples a therapeutic radionuclide, or radioactive isotope, with a cancer-specific cell-targeting module called the ligand. The radioactive isotope, or radionuclide, is a typically unstable atom (specifically defined by the number of protons and neutrons), which emits radiation as it transforms into a more stable form. […]
Emerging Radionuclides in RLT: What Developers Need to Know Read More »










